▲ Peaking
Health
FDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team
The FDA approves a once-daily Parkinson's pill, marking the first new drug class in half a century.
Tavapadon
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease
The FDA has approved Juvmo, a first-in-class Parkinson's disease medication, validating AbbVie's $8.7 billion acquisition of Cerevel.